Arcutis Biotherapeutics, Inc. Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.

ARQT

Hisse Senetlerindeki Sıralama #3982
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Hisse Fiyatı
$32.88
Son senkronizasyon: 2026-10-20
Piyasa Değeri
$4.13B
Değişim (1 gün)
3.11%
Değişim (1 yıl)
59.32%
Ülke
US
Ticaret Arcutis Biotherapeutics, Inc. (ARQT)

Kategori

Healthcare
Arcutis Biotherapeutics, Inc. (ARQT) için gelir
Jun 2026 itibarıyla gelir TTM: $463.98M
Arcutis Biotherapeutics, Inc. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $463.98M'dir. 2023 yılında şirketin geliri $59.61M önceki yıla göre artış 2022 yılındaki $3.69M gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Arcutis Biotherapeutics, Inc. için 2017 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
2026 (TTM) $463.98M 136.07%
2024 $196.54M 229.74%
2023 $59.61M 1,517.09%
2022 $3.69M 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 2,620.87%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 380.19%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B 3,293.31%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 1,197.74%
NL